[F1 SCHEDULE SElements that must be included in a prescription issued in a Member State other than the Member State where it is intended to be used

Textual Amendments

F1 Sch. inserted (31.3.2015) by The National Health Service (Cross-Border Health Care) (Scotland) Amendment Regulations 2015 (S.S.I. 2015/91), regs. 1(1), 2(1)(c)

4.   The details of the prescribed product, including where applicable the— S

(a) common name as defined by Article 1 of Directive 2001/83/EC;

(b) brand name if—

(i) the prescribed product is a biological medicinal product as referred to in point 3.2.1.1.(b) of Annex 1 (Part 1) to Directive 2001/83/EC; or

(ii) the prescribing professional deems it medically necessary for that product to be dispensed and, in that case, the prescribing professional’s reasons justifying the use of the brand name;

(c) pharmaceutical formulation (such as tablet, solution etc.);

(d) quantity;

(e) strength as defined in Article 1 of Directive 2001/83/EC; and

(f) dosage regimen.]